Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Tonix Pharmaceuticals Holding (TNXP) Shares Repurchased (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Shares Repurchased over the past 3 years, most recently at $68000.0 for Q4 2025.

  • Quarterly results put Shares Repurchased at $68000.0 for Q4 2025, down 92.39% from a year ago — trailing twelve months through Dec 2025 was $4.3 million (down 10.09% YoY), and the annual figure for FY2025 was $6.0 million, up 25.93%.
  • Shares Repurchased for Q4 2025 was $68000.0 at Tonix Pharmaceuticals Holding, down from $1.9 million in the prior quarter.
  • Over the last five years, Shares Repurchased for TNXP hit a ceiling of $12.5 million in Q1 2023 and a floor of $68000.0 in Q4 2025.
  • Median Shares Repurchased over the past 3 years was $1.4 million (2025), compared with a mean of $2.4 million.
  • Peak annual rise in Shares Repurchased hit 85.26% in 2025, while the deepest fall reached 92.39% in 2025.
  • Tonix Pharmaceuticals Holding's Shares Repurchased stood at $2.1 million in 2023, then tumbled by 57.0% to $894000.0 in 2024, then crashed by 92.39% to $68000.0 in 2025.
  • The last three reported values for Shares Repurchased were $68000.0 (Q4 2025), $1.9 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.